HARTFORD, Conn. — Cigna directors and officers face a federal shareholder derivative complaint three months after shares plummeted upon news that the U.S. government sanctioned the company’s deficient appeals and grievances procedures.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

